AA
Ascentage Pharma Group International
AAPG · NASDAQ
$15.06 -2.02% (-$0.31)
1M -9.87%
Market Cap ¥2.34B
P/E Ratio -
Div. Yield -
ROE 171.96%
Piotroski F-Score Weak
2/9Valuation
68 /100
Cheap P/B 1.77x
P/S 4.19x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 48.02%
Rev. growth 38.61%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 211.14%
Gross margin 76.41%
FCF margin 215.17%
Quality
2 /100
Poor ROA 30.48%
ROIC 33.45%
Asset turnover 0.14x
Debt
37 /100
Moderate Int. coverage -22.42x
Debt/Equity 1.49x
Current ratio 1.79x
Stability
26 /100
Unstable EPS volatility 122.93%
Beta 0.66x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AAPG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Upcoming events
31 MAR
Earnings
Upcoming earnings report